Malaria

WHO releases technical brief on control and elimination of P. vivax malaria

A mother and her daughter at Delhi railway Station.
WHO /Tom Pietrasik

29 July 2015 – At a global meeting in New Delhi, WHO released today a new document which describes strategies aimed at controlling and eliminating Plasmodium vivax, the cause of an estimated 16 million malaria cases worldwide in 2013. The technical brief covers several key strategic areas: diagnostic testing and treatment of P. vivax infections, G6PD deficiency and radical cure with primaquine, and surveillance. Organized with the support of Medicines for Malaria Venture, the meeting shines a spot-light on the importance of tackling P. vivax to achieve elimination targets in the Global Technical Strategy for Malaria 2016–2030.

World Health Assembly adopts new global malaria strategy

Photo of World Health Assembly Committee A
WHO/Christopher Black

20 May 2015 – The World Health Assembly has adopted a new global technical strategy for malaria, setting ambitious goals and targets for the next 15 years. Forty-one countries took the floor during the discussion – including Malawi speaking on behalf of the 47 countries of the African Region, and Indonesia speaking on behalf of the 11 countries of the South-East Asia Region. By adopting this strategy, Member States have set the target of reducing global malaria incidence and mortality rates by 90% by 2030.

World Malaria Day: new guidelines on the treatment of malaria

The Global Fund / John Rae

22 April 2015 – On the occasion of World Malaria Day 2015 (25 April), WHO is releasing the third edition of the Guidelines for the treatment of malaria. The updated guidelines provide evidence-based recommendations on the diagnosis and treatment of uncomplicated and severe malaria, and on the use of medicines to prevent malaria in high-risk groups.

Highlights

Latest news

25 July 2015 – Updated Q&A on RTS,S/AS01 malaria vaccine candidate

WHO has published an updated Q&A about RTS,S/AS01, a malaria vaccine being developed through a partnership between GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative.

13 July 2015 – Next Malaria Policy Advisory Committee (MPAC) meeting

The next MPAC meeting will take place in Geneva, Switzerland from 16 to 18 September 2015. The first 2 days of the meeting are open to the public but advance registration is required.

7 July 2015 – Call for expressions of interest for Round 7 of the WHO Malaria RDT Product Testing Programme

Round 7 of the WHO Product Testing Programme is due to commence in November 2015. Deadline for submitting requests for participation was 30 July.

26 June 2015 – New publication: Second edition of IRS operational manual

The indoor residual spraying manual has been updated to reflect the latest WHO recommendations. The document is recommended for national malaria control programmes and technical partners working on IRS programmes.

22 May 2015 – Malaria elimination strategy for the Greater Mekong subregion

WHO has released the Strategy for malaria elimination in the Greater Mekong subregion (2015–2030). The document was drafted under the aegis of the Regional Hub for the Emergency Response to Artemisinin Resistance in coordination with countries and regional partners.

28 April 2015 – Nominations open for 2015 Malaria Champions of the Americas awards

The 2015 awards will recognize initiatives that have contributed to the achievement of MDG targets, including those related to malaria. Nominations can be submitted until 22 June and winners will be announced on Malaria Day in the Americas (6 November).

World Malaria Report 2014

This report contains the latest available data on malaria policies, interventions and trends in all endemic countries.

Global Technical Strategy for Malaria 2016-2030

Adopted by the World Health Assembly in May 2015, this strategy aims to reduce global malaria incidence and mortality rates by 90% by 2030.

Contact us

Global Malaria Programme
World Health Organization
20 Avenue Appia
1211 Geneva 27
Switzerland
Tel: +41 22 791 2533
Fax: +41 22 791 4824
E-mail: infogmp@who.int